Results 151 to 160 of about 187,275 (304)

Heparin Anticoagulant Therapy and Its Monitoring. [PDF]

Biomolecules
Reardon B, Pasalic L, Lippi G, Favaloro EJ.   +3 more
europepmc   +1 more source

The quantitative impact of metabolism‐inhibiting drugs on the occurrence of adverse drug reactions—A backward selection approach

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The quantitative effect of several inhibitory drugs on the development of adverse drug reactions (ADRs) is currently difficult to estimate. Our aim was to identify metabolic pathways, which, when inhibited, increase the risk for certain ADRs, and to use this system to consider comedication at individual level. Methods Data of a prospective
Judith Berres, Justyna Wozniak, Hannah Fölsch, Anja Knueppel‐Ruppert, Verena Graeff, Andrea Kriegisch‐Stumpf, Harald Dormann, Julia C. Stingl, Katja S. Just   +8 more
wiley   +1 more source

Efficacy and safety of anticoagulant therapy in sepsis: A systematic review and meta-analysis. [PDF]

J Int Med Res
Lu J, Zhang Z, Wang L.
europepmc   +1 more source

Intestinal transplantation for patients with short gut syndrome and hypercoagulable states [PDF]

, 2000
Abu-Elmagd, K, Bueno, J, Colangelo, J, Fung, JJ, Giraldo, M, Martin, D, Reyes, J, Starzl, TE   +7 more
core   +1 more source

Mimic, target, and adapt: Cell membrane‐coated nanoplatforms for precision and immune‐guided cancer treatment

BMEMat, EarlyView.
This Perspective explores the emerging landscape of cell membrane‐coated nanoparticles (CM‐NPs) as intelligent, immune‐compatible platforms for cancer therapy. Highlighting design strategies, translational challenges, and competitive positioning, it outlines how integrating biomimetic targeting with advanced analytical and manufacturing tools could ...
A. K. M. M. Alam, Xiaojun Cai, Malik Ihsan Ullah Khan, Robert Musiol, Quazi T. H. Shubhra   +4 more
wiley   +1 more source

Anticoagulant therapy in patients with cancer and thrombocytopenia. [PDF]

J Thromb Thrombolysis
Szmit S, Kępski J, Lech-Marańda E, Kowalski DM, Krzakowski M, Zaborowska-Szmit M.   +5 more
europepmc   +1 more source

Management of severe bone loss in patients at risk of medication‐related osteonecrosis of the jaw with microsurgery and guided bone regeneration: A case study

Clinical Advances in Periodontics, EarlyView.
Abstract Background Medication‐related osteonecrosis of the jaw (MRONJ) is a challenging complication associated with antiresorptive medications. Its exact pathophysiology remains unclear, but dental extractions and infections are known triggers, complicating prevention, and treatment.
Pedro Franco Ferreira, José Maurício Paradella de Camargo, Lara Maria Alencar Ramos Innocentini, Ana Carolina Fragoso Motta   +3 more
wiley   +1 more source

Comprehensive Nursing Management of Anticoagulation and Heart Failure Surveillance in a Chinese Patient With Mirror‐Image Dextrocardia Post‐MitraClip Surgery: A First Case Report

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Mitral regurgitation (MR) is the valent type of valvular heart disease, caused by primary leaflet lesions or annular dilatation secondary to left ventricular dysfunction. It can lead to a series of complications such as volume overload, exacerbated pulmonary congestion, and heart failure, significantly impacting patient prognosis ...
Juelian Li, Chun Wu, Chao Shang, Yu Deng, Jinxia Zhang   +4 more
wiley   +1 more source

Anticoagulant Therapy [PDF]

BMJ, 1962
J. O. Winter, I. Surveyor
openaire   +3 more sources

Effect of enzalutamide on anticoagulant therapy with edoxaban in patients with prostate cancer. [PDF]

Br J Clin Pharmacol
Op 't Hoog CJP, Mehra N, van Kleef A, Somford DM, van Oort IM, Imholz ALT, Hamberg P, van Erp NP, Boerrigter E.   +8 more
europepmc   +1 more source